Eino B. van Duyn
Papers
5
Total Citations
80
H-Index
3
About
Eino B. van Duyn is a surgical researcher whose work is reshaping how we think about recovery and quality of life after cancer surgery. His primary research areas are minimally invasive surgical techniques for pancreatic and rectal cancers, with a sharp focus on functional outcomes, cost-effectiveness, and patient-reported quality of life. Van Duyn’s major contributions include leading the landmark LEOPARD trial, which demonstrated that minimally invasive distal pancreatectomy reduces recovery time and is cost-effective compared to open surgery—a finding that has influenced clinical guidelines and earned 55 citations. He has also conducted comprehensive meta-analyses comparing open, laparoscopic, robot-assisted, and transanal total mesorectal excision (TME) for rectal cancer, revealing critical differences in functional outcomes that help surgeons choose the best approach for each patient. His work on predictors of positive circumferential resection margins in robot-assisted TME provides a risk model that could improve surgical planning and reduce recurrence rates. With a growing portfolio of multicenter studies like the EUREKA collaborative, van Duyn is building the evidence base for personalized, minimally invasive cancer care that prioritizes both survival and quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5